Cited by 19Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesChild and Adolescent Psychosocial and Emotional DevelopmentTreatment of Major Depression

Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis

Open access
Stefánsdóttir, Íris Harpa, Ivarsson, Tord, Skarphedinsson, Gudmundur·2023·Nordic Journal of Psychiatry

Abstract

PURPOSE: To assess the efficacy and safety of selective serotonin reuptake inhibitors (SSRIs) and selective noradrenaline reuptake inhibitors (SNRIs) in comparison with various control contingencies (e.g. pill placebo and cognitive behavioral treatment) for pediatric anxiety disorders. Additionally, we wanted to investigate whether serious adverse events or adverse events are more common with medication treatment compared with pill placebo. MATERIALS AND METHODS: Studies were selected if they were randomized controlled trials evaluating SSRIs or SNRIs. Eligible studies included participants aged 17 years or younger. Eleven studies were included, with 2122 participants. Primary outcomes were (1) remission, (2) a continuous scale such as the Social Phobia and Anxiety Inventory for Children and (3) serious adverse events. We also calculated number needed to treat and number needed to harm. RESULTS: SSRIs and SNRIs are an effective treatment of childhood anxiety disorders and are superior to pill placebo. While the risk of serious adverse events was low with SSRI/SNRI treatment, there was an increased risk of experiencing behavioral activation with SSRI/SNRI treatment. CONCLUSION: SSRI and SNRI treatment is effective for childhood anxiety disorders, with positive effect of treatment outweighing the negative effects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/08039488.2022.2075460

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Socialstyrelsen, 2017, Nationella riktlinjer för vård vid depression och ångestsyndrom – stöd för styrning och ledning [the Swedish national clinical guidelines for anxiety and affective disorders: Support for management and administration]
  2. Garland EJ, 2016, J Canadian Acad Child Adolesc Psychiatry, 25, 4
  3. Storebø OJ, 2015, Cochrane Database Syst Rev, 2016
  4. La Greca A., 1998, Manual for social anxiety scales for children and adolescents

Cited by

Sorted by citations

Authors
Stefánsdóttir, Í. H., Ivarsson, T., & Skarphedinsson, G.
Affiliations
  • University of Iceland (IS)
  • University of Gothenburg (SE)
  • Faculty of Psychology, University of Iceland, Reykjavík, Iceland
Venue
Nordic Journal of Psychiatry
Published
2022-05-19
Volume
77
Issue
2
Pages
137-146
ISSN
  • 0029-1455 (ISSN-L)
  • 0803-9488
  • 1502-4725
OpenAlex
W4280559176
Cited by
19
References
42
Citations by year
2026: 7 · 2025: 4 · 2024: 4 · 2023: 4
FWCI
0.44
Type
journal article
Language
en
Open access
Locations
  • Nordic Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Skemman (submittedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
selective serotonin reuptake inhibitors, selective noradrenaline reuptake inhibitors, childhood anxiety disorders, children and adolescents, antidepressant efficacy, adverse drug reactions, behavioral activation, placebo comparison, cognitive behavioral therapy, number needed to harm, number needed to treat
MeSH terms
Serotonin and Noradrenaline Reuptake Inhibitors, Adolescent, Anxiety Disorders, Child, Humans, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review